A neuronal enhancer network upstream of MEF2C is compromised in patients with Rett-like characteristics.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 07 09 2018
revised: 01 11 2018
accepted: 08 11 2018
pubmed: 18 11 2018
medline: 12 3 2020
entrez: 17 11 2018
Statut: ppublish

Résumé

Mutations in myocyte enhancer factor 2C (MEF2C), an important transcription factor in neurodevelopment, are associated with a Rett-like syndrome. Structural variants (SVs) upstream of MEF2C, which do not disrupt the gene itself, have also been found in patients with a similar phenotype, suggesting that disruption of MEF2C regulatory elements can also cause a Rett-like phenotype. To characterize those elements that regulate MEF2C during neural development and that are affected by these SVs, we used genomic tools coupled with both in vitro and in vivo functional assays. Through circularized chromosome conformation capture sequencing (4C-seq) and the assay for transposase-accessible chromatin using sequencing (ATAC-seq), we revealed a complex interaction network in which the MEF2C promoter physically contacts several distal enhancers that are deleted or translocated by disease-associated SVs. A total of 16 selected candidate regulatory sequences were tested for enhancer activity in vitro, with 14 found to be functional enhancers. Further analyses of their in vivo activity in zebrafish showed that each of these enhancers has a distinct activity pattern during development, with eight enhancers displaying neuronal activity. In summary, our results disentangle a complex regulatory network governing neuronal MEF2C expression that involves multiple distal enhancers. In addition, the characterized neuronal enhancers pose as novel candidates to screen for mutations in neurodevelopmental disorders, such as Rett-like syndrome.

Identifiants

pubmed: 30445463
pii: 5184337
doi: 10.1093/hmg/ddy393
pmc: PMC6381311
doi:

Substances chimiques

MEF2 Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-827

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press.

Références

Nat Biotechnol. 2014 Jan;32(1):71-5
pubmed: 24336318
Am J Med Genet A. 2011 Nov;155A(11):2879-84
pubmed: 21990267
Genome Res. 2005 Aug;15(8):1034-50
pubmed: 16024819
Sci Rep. 2017 Sep 25;7(1):12288
pubmed: 28947817
Development. 2004 Aug;131(16):3931-42
pubmed: 15253934
Methods Enzymol. 2012;513:89-112
pubmed: 22929766
Clin Genet. 2012 Nov;82(5):499-501
pubmed: 22449245
Genet Med. 2011 Sep;13(9):777-84
pubmed: 21844811
Am J Med Genet A. 2009 Nov;149A(11):2581-3
pubmed: 19876902
Neurology. 2009 Mar 3;72(9):784-92
pubmed: 19073947
Nature. 2014 Mar 27;507(7493):462-70
pubmed: 24670764
Nucleic Acids Res. 2017 Jan 4;45(D1):D626-D634
pubmed: 27899642
Dev Dyn. 2005 Oct;234(2):244-54
pubmed: 16110506
J Pediatr Genet. 2017 Sep;6(3):129-141
pubmed: 28794905
Mol Neurodegener. 2017 Jan 24;12(1):10
pubmed: 28118852
Methods Mol Biol. 2013;1078:9-21
pubmed: 23975817
Cancer Res. 2016 Sep 15;76(18):5523-37
pubmed: 27635046
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Dev Biol. 2004 Nov 15;275(2):424-34
pubmed: 15501228
J Med Genet. 2010 Jan;47(1):22-9
pubmed: 19592390
Nature. 2014 Mar 27;507(7493):455-461
pubmed: 24670763
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Nat Genet. 2017 Jan;49(1):36-45
pubmed: 27841880
Mol Cell. 2015 Nov 19;60(4):676-84
pubmed: 26527277
Eur J Med Genet. 2016 Sep;59(9):478-82
pubmed: 27255693
Genome Biol. 2018 Oct 4;19(1):151
pubmed: 30286773
Science. 1997 May 30;276(5317):1404-7
pubmed: 9162005
Brain Res Mol Brain Res. 2001 Dec 16;97(1):70-82
pubmed: 11744164
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Nature. 2018 Mar 29;555(7698):611-616
pubmed: 29562236
Eur J Hum Genet. 2014 May;22(5):652-9
pubmed: 24105367
Nucleic Acids Res. 2007 Jan;35(Database issue):D88-92
pubmed: 17130149
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9391-6
pubmed: 18599438
Mech Dev. 2003 Sep;120(9):1021-32
pubmed: 14550531
Genome Res. 2001 Dec;11(12):1979-87
pubmed: 11731487
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Am J Med Genet A. 2016 May;170A(5):1352-7
pubmed: 26864752
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Development. 2007 Dec;134(23):4131-40
pubmed: 17959722
Neuroscience. 1994 Dec;63(4):1067-79
pubmed: 7700509
Dev Dyn. 2010 Sep;239(9):2443-51
pubmed: 20652955
Eur J Hum Genet. 2009 Dec;17(12):1592-9
pubmed: 19471318
Hum Mutat. 2010 Jun;31(6):722-33
pubmed: 20513142
Cell. 2008 Dec 12;135(6):1053-64
pubmed: 19070576
Development. 1994 May;120(5):1251-63
pubmed: 8026334
BMC Bioinformatics. 2017 May 2;18(1):231
pubmed: 28464823
Eur J Hum Genet. 2008 Jun;16(6):696-704
pubmed: 18270536
Mol Psychiatry. 2018 Jan;23(1):123-132
pubmed: 28115742
Dev Biol. 2010 Jan 15;337(2):484-95
pubmed: 19850031

Auteurs

Eva D'haene (E)

Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium.

Reut Bar-Yaacov (R)

Department of Life Sciences, Faculty of Natural Sciences, The Ben-Gurion University of the Negev, Beersheba, Israel.
Center of Evolutionary Genomics and Medicine, The Ben-Gurion University of the Negev, Beersheba, Israel.

Inbar Bariah (I)

Department of Life Sciences, Faculty of Natural Sciences, The Ben-Gurion University of the Negev, Beersheba, Israel.
Center of Evolutionary Genomics and Medicine, The Ben-Gurion University of the Negev, Beersheba, Israel.

Lies Vantomme (L)

Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium.

Sien Van Loo (S)

Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium.

Francisco Avila Cobos (FA)

Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
Bioinformatics Institute Ghent from Nucleotides to Networks (BIG N2N), Ghent, Belgium.

Karen Verboom (K)

Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.

Reut Eshel (R)

Department of Life Sciences, Faculty of Natural Sciences, The Ben-Gurion University of the Negev, Beersheba, Israel.
Center of Evolutionary Genomics and Medicine, The Ben-Gurion University of the Negev, Beersheba, Israel.

Rawan Alatawna (R)

Department of Life Sciences, Faculty of Natural Sciences, The Ben-Gurion University of the Negev, Beersheba, Israel.
Center of Evolutionary Genomics and Medicine, The Ben-Gurion University of the Negev, Beersheba, Israel.

Björn Menten (B)

Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium.

Ramon Y Birnbaum (RY)

Department of Life Sciences, Faculty of Natural Sciences, The Ben-Gurion University of the Negev, Beersheba, Israel.
Center of Evolutionary Genomics and Medicine, The Ben-Gurion University of the Negev, Beersheba, Israel.

Sarah Vergult (S)

Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH